國藥集團,集研發、生產、銷售、服務于一體的現代化綜合型制藥企業,擁有化學原料藥/無菌頭孢類抗生素原料藥/口服固體制劑/注射用粉針劑/中西藥口服液體制劑等產品
國(guo)藥(yao)(yao)(yao)集(ji)(ji)團(tuan)汕頭(tou)金石制藥(yao)(yao)(yao)有限公(gong)(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)(原汕頭(tou)金石制藥(yao)(yao)(yao)總廠)是中國(guo)醫藥(yao)(yao)(yao)集(ji)(ji)團(tuan)有限公(gong)(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)(國(guo)藥(yao)(yao)(yao)集(ji)(ji)團(tuan))所屬(shu)企業。2016年,根據國(guo)藥(yao)(yao)(yao)集(ji)(ji)團(tuan)化藥(yao)(yao)(yao)平臺整(zheng)合要求(qiu),國(guo)藥(yao)(yao)(yao)集(ji)(ji)團(tuan)所屬(shu)上市(shi)公(gong)(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)——上海(hai)現(xian)(xian)(xian)代制藥(yao)(yao)(yao)股(gu)(gu)份有限公(gong)(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)完成對公(gong)(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)的(de)重整(zheng),公(gong)(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)現(xian)(xian)(xian)為(wei)上海(hai)現(xian)(xian)(xian)代制藥(yao)(yao)(yao)股(gu)(gu)份有限公(gong)(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)的(de)全資子公(gong)(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)。
歷經多(duo)年發(fa)展(zhan),公(gong)司(si)(si)(si)現已發(fa)展(zhan)成為具(ju)有(you)(you)化(hua)學原料(liao)藥(yao)、無菌(jun)頭(tou)孢類(lei)抗(kang)生(sheng)(sheng)素(su)(su)(su)原料(liao)藥(yao)、口服(fu)固體(ti)制(zhi)劑(ji)(ji)(ji)、注射用粉(fen)(fen)針(zhen)劑(ji)(ji)(ji)和中(zhong)西藥(yao)口服(fu)液體(ti)制(zhi)劑(ji)(ji)(ji)等集(ji)研發(fa)、生(sheng)(sheng)產、銷(xiao)售(shou)、服(fu)務于一(yi)(yi)體(ti)的(de)(de)現代(dai)化(hua)、綜合型(xing)制(zhi)藥(yao)企(qi)(qi)業,是(shi)汕(shan)頭(tou)金(jin)(jin)石粉(fen)(fen)針(zhen)劑(ji)(ji)(ji)有(you)(you)限公(gong)司(si)(si)(si)、國藥(yao)集(ji)團(tuan)汕(shan)頭(tou)金(jin)(jin)石抗(kang)菌(jun)素(su)(su)(su)有(you)(you)限公(gong)司(si)(si)(si)的(de)(de)控股股東(dong)。 公(gong)司(si)(si)(si)本(ben)部擁(yong)有(you)(you)制(zhi)藥(yao)品(pin)種批(pi)文(wen)154個,汕(shan)頭(tou)金(jin)(jin)石粉(fen)(fen)針(zhen)劑(ji)(ji)(ji)有(you)(you)限公(gong)司(si)(si)(si)擁(yong)有(you)(you)不同(tong)品(pin)種批(pi)文(wen)65個,國藥(yao)集(ji)團(tuan)汕(shan)頭(tou)金(jin)(jin)石抗(kang)菌(jun)素(su)(su)(su)有(you)(you)限公(gong)司(si)(si)(si)擁(yong)有(you)(you)無菌(jun)頭(tou)孢類(lei)抗(kang)生(sheng)(sheng)素(su)(su)(su)原料(liao)藥(yao)4個品(pin)種,尚有(you)(you)一(yi)(yi)批(pi)在研及(ji)申報品(pin)種;本(ben)部及(ji)屬下所(suo)有(you)(you)生(sheng)(sheng)產線均通過(guo)2010年版GMP認證(zheng)。全企(qi)(qi)業(含屬下二個合資(zi)公(gong)司(si)(si)(si))在職員工(gong)六百(bai)多(duo)人(ren),擁(yong)有(you)(you)一(yi)(yi)支(zhi)素(su)(su)(su)養較(jiao)(jiao)高、實力較(jiao)(jiao)雄厚(hou)的(de)(de)生(sheng)(sheng)產、技術、經營(ying)和管理隊(dui)伍,其中(zhong)各類(lei)專業技術人(ren)員三百(bai)多(duo)人(ren)。
“精誠所(suo)至(zhi),金(jin)(jin)石為(wei)(wei)開(kai)”,國(guo)(guo)藥(yao)金(jin)(jin)石,以(yi)優質產(chan)品(pin)為(wei)(wei)載體(ti),以(yi)誠待客,誠信經營(ying),在國(guo)(guo)內外樹立了良好的(de)企業(ye)形象,產(chan)品(pin)出口歐洲、非洲、東南亞(ya),如德國(guo)(guo)、荷蘭、非洲、法國(guo)(guo)、日本等(deng)國(guo)(guo)家或地區。“雙(shuang)贏、多贏、合作、誠信”,是(shi)建設(she)和(he)諧國(guo)(guo)藥(yao)金(jin)(jin)石的(de)重(zhong)要保障(zhang)和(he)生動體(ti)現。國(guo)(guo)藥(yao)金(jin)(jin)石正以(yi)科技創新(xin)為(wei)(wei)先導,以(yi)改革為(wei)(wei)動力,以(yi)海納百(bai)川的(de)胸襟,聚眾(zhong)才(cai),匯眾(zhong)力,穩步邁(mai)向(xiang)新(xin)境界(jie)。
放眼未來(lai),公(gong)司(si)將一如既往秉(bing)承“關愛生命 呵護健(jian)康”的國藥理(li)念,堅(jian)持“誠信經(jing)(jing)營,質(zhi)量(liang)第一”的經(jing)(jing)營宗旨,為建設(she)國藥集團制藥產業基(ji)地而努(nu)力,滿(man)懷真誠和期望(wang)與各(ge)界朋友(you)攜(xie)手共謀(mou)事業、共圖發展。